Seer proxy fight with Radoff
Analysis based on 13 articles · First reported Jul 08, 2026 · Last updated Jul 30, 2026
The proxy contest introduces uncertainty about Seer's strategic direction, potentially affecting investor sentiment and stock price. A successful activist campaign could lead to a sale of the company or changes in capital allocation, while a board victory may reinforce current strategy.
Seer, Inc., a proteomics company, is facing a proxy contest from activist investors Bradley L. Radoff and Michael ahead of its 2026 Annual Meeting of Stockholders on July 28, 2026. Radoff and Torok are seeking to replace three incumbent directors - Omid Farokhzad, Terrance McGuire, and Dipchand Nishar - with their own nominees, whom Seer's board claims lack relevant experience. Seer's board has urged stockholders to vote for its seven nominees on the BLUE proxy card, emphasizing the board's qualifications and long-term value creation strategy. The board collectively owns 17% of Seer's outstanding shares. Radoff and Torok are accused of seeking an early sale of the company and stripping its cash. Seer has engaged Perella Weinberg Partners as financial advisor and Wilson Sonsini Goodrich & Rosati as legal counsel.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard